Expert Insights

2026 Trends Shaping CNS Clinical Research

What Psychedelic Clinical Trials Need Now: Key Takeaways from the Bold Conversation

Speed Kills: Is Your Neuropsychiatric Trial at Risk?

The Renaissance of Psychedelic Research: History, Protocols, and Forward Trajectories

The Expanding Role of GLP-1 Receptor Agonists in CNS Clinical Research

4 Ways Strategic Site Selection Maximizes the Value Equation

Next-Day Effects: Are Medications Leaving Drivers at Risk?